Ondansetron
2 mg/ml 4 ml № 5
Pharmacotherapeutic group
Active ingredient
Pharmaceutical form
Solution for injections
ATC code
A04AA01
RX/OTC
RX
Registration certificate
UA/10250/01/01
General properties
Pharmacotherapeutic group
Antiemetic means and preparations, eliminating nausea. The antagonists of serotonin receptors (5НТЗ). Ondansetron.
Therapeutic indications
- Nausea and vomiting caused by cytotoxic chemotherapy and radiotherapy.
- Prevention and treatment of postoperative nausea and vomiting.
Contraindications
The use of ondansetron with apomorphine hydrochloride is contraindicated, as observed cases of severe hypotension and loss of consciousness during a joint application.
Hypersensitivity to any component of the formulation.
Pharmaceutical characteristics
Main physicochemical properties
Clear colorless liquid.
Shelf life
2 years.
Storage
Keep out of reach of children in original packaging at temperature not exceeding 30 °С.
Manufacturer
PJSC "Lekhim-Kharkiv".
Location
36, Severyna Pototskoho St., 61115 Kharkiv, Ukraine.
